Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ST-100 (vezocolmitide) in Dry Eye Disease
NCT06178679Phase 3Recruiting
- Start
- Dec 2023
- Primary completion
- Jun 2024
- Modality
- Small Molecules, Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of vezocolmitide in dry eye disease (DED). Started Dec 2023; status: recruiting.
02
Drugs
vezocolmitide
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT06178679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06178679.